![Pathophysiology of late-onset Pompe disease. Abbreviations: GAA, acid... | Download Scientific Diagram Pathophysiology of late-onset Pompe disease. Abbreviations: GAA, acid... | Download Scientific Diagram](https://www.researchgate.net/publication/283830410/figure/fig3/AS:296548907929604@1447714177311/Pathophysiology-of-late-onset-Pompe-disease-Abbreviations-GAA-acid-alpha-glucosidase.png)
Pathophysiology of late-onset Pompe disease. Abbreviations: GAA, acid... | Download Scientific Diagram
![Muscle weakness in adults with Pompe disease. Distribution of skeletal... | Download Scientific Diagram Muscle weakness in adults with Pompe disease. Distribution of skeletal... | Download Scientific Diagram](https://www.researchgate.net/profile/Baziel-Van-Engelen/publication/233404633/figure/fig2/AS:202697836896260@1425338338821/Muscle-weakness-in-adults-with-Pompe-disease-Distribution-of-skeletal-muscle-weakness_Q320.jpg)
Muscle weakness in adults with Pompe disease. Distribution of skeletal... | Download Scientific Diagram
![Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study | Scientific Reports Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-29170-7/MediaObjects/41598_2018_29170_Fig1_HTML.png)
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study | Scientific Reports
![Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder](https://www.mdpi.com/biomolecules/biomolecules-10-01339/article_deploy/html/images/biomolecules-10-01339-g001.png)
Biomolecules | Free Full-Text | Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
![Marrow on X: "The @US_FDA Approved Nexviazyme (avalglucosidase alfa-ngpt) For Late-Onset Pompe Disease Recommended dose: 20 mg/kg for patients ≥30 kg OR 40 mg/kg for patients <30 kg | #medtwitter https://t.co/CZN4NK0X2n" / Marrow on X: "The @US_FDA Approved Nexviazyme (avalglucosidase alfa-ngpt) For Late-Onset Pompe Disease Recommended dose: 20 mg/kg for patients ≥30 kg OR 40 mg/kg for patients <30 kg | #medtwitter https://t.co/CZN4NK0X2n" /](https://pbs.twimg.com/media/E8gDnNDUcAA2py-.jpg)
Marrow on X: "The @US_FDA Approved Nexviazyme (avalglucosidase alfa-ngpt) For Late-Onset Pompe Disease Recommended dose: 20 mg/kg for patients ≥30 kg OR 40 mg/kg for patients <30 kg | #medtwitter https://t.co/CZN4NK0X2n" /
![JCM | Free Full-Text | A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease JCM | Free Full-Text | A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease](https://pub.mdpi-res.com/jcm/jcm-10-04828/article_deploy/html/images/jcm-10-04828-g001.png?1635145343)